class,class_long,nameTKI,tyrosine kinase inhibitors,erlotinibTKI,tyrosine kinase inhibitors,gefitinibTKI,tyrosine kinase inhibitors,afatinibTKI,tyrosine kinase inhibitors,dacomitinibTKI,tyrosine kinase inhibitors,osimertinibPBDC,platinum-based doublet chemotherapy,PBDCanti-VEGF,anti vascular endothelial growth factor,bevacizumabICI,immune checkpoint inhibitor,nivolumabICI,immune checkpoint inhibitor,pembrolizumabICI,immune checkpoint inhibitor,atezolizumab